Amniotic Membrane for Corneal Diseases. Properties and Applications. Literature Review

Inflammatory diseases of the cornea, its injuries and burns are the leading causes of decreased vision, blindness and death of the eye. The search for the new and effective methods of treating corneal diseases with a recurrent course is a pressing issue. This article is devoted to modern information on the possibilities of using Amniotic Membrane (AM) in the treatment of patients with severe corneal pathology: persistent epithelial erosions, corneal perforations and disorders associated with limbal stem cell deficiency. The advantages and disadvantages of various methods of AM preservation, methods of using AM in surgical and conservative treatment, as well as various complications that may be encountered when using AM are presented.

1. Deev LA, Yartseva NS. Diseases of the corneal treatment of the eyeball. Russian ophthalmology online (In Russ.). URL: https://eyepress.ru/article.aspx?9358 (access date: 3.12.2024).

2. Brzheskaya IV, Somov EE. Collagenolytic activity of conjunctival fluid in healthy people and patients with aseptic ulcer of the cornea of various etiologies. RMJ. Clinical ophthalmology. 2018;2:77–80 (In Russ.).

3. Corrêa MEAB, Silveira PCL. Amniotic membrane in wound healing: new perspectives. J Wound Care. 2024;33(8):612–616. doi: 10.12968/jowc.2022.0054.

4. Jirsova K, Jones GLA. Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting-a review. Cell Tissue Bank. 2017;18(2):193–204. doi: 10.1007/s10561-017-9618-5.

5. Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011;108(14):243–248. doi: 10.3238/arztebl.2011.0243.

6. Ailamazyan EK, Kalashnikova EP, Tanakov AI. Morphofunctional features of the amnion in normal and pathological pregnancy. Obstetrics and gynecology. 1993;5:3–6 (In Russ.).

7. Kasparov AA, Trufanov SV. Use of preserved amniotic membrane for reconstruction of the anterior segment surface of the eyeball. Annals of Ophthalmology 2001;3:45–47 (In Russ.).

8. Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol. 1999;83(6):748–752. doi: 10.1136/bjo.83.6.748.

9. Niknejad H, Peirovi H, Jorjani M. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008;15:88–99. doi: 10.22203/ecm.v015a07.

10. Mamede AC, Carvalho MJ, Abrantes AM. Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res. 2012;349(2):447–458. doi: 10.1007/s00441-012-1424-6.

11. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 1995;267(5199):891–893. doi: 10.1126/science.7531366.

12. He H, Kuriyan AE, Su CW. Inhibition of Proliferation and Epithelial Mesenchymal Transition in Retinal Pigment Epithelial Cells by Heavy Chain-Hyaluronan/Pentraxin 3. Sci Rep. 2017;7:43736. doi: 10.1038/srep43736.

13. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49(1):51–77. doi: 10.1016/j.

14. Vertieva EYu, Olisova OYu, Kochergin NG, Pinson IYa. Review of pathogenetic mechanisms and methods of scar correction. Russian Journal of Skin and Venereal Diseases. 2015;1:51–57 (In Russ.).

15. Adinolfi M, Akle CA, McColl I. Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature. 1982;295(5847):325–327. doi: 10.1038/295325a0.

16. Kubo M, Sonoda Y, Muramatsu R, Usui M. Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1539–1546.

17. Adds PJ, Hunt CJ, Dart JK. Amniotic membrane grafts, “fresh” or frozen? A clinical and in vitro comparison. Br J Ophthalmol. 2001;85(8):905–907. doi: 10.1136/bjo.85.8.905.

18. Kim JS, Kim JC, Hahn TW, Park WC. Amniotic membrane transplantation in infectious corneal ulcer. Cornea. 2001;20(7):720–726. doi: 10.1097/00003226200110000-00010.

19. Malhotra C, Jain AK. Human amniotic membrane transplantation: Different modalities of its use in ophthalmology. World J Transplant. 2014;4(2):111–121. doi: 10.5500/wjt.v4.i2.111.

20. Baradaran-Rafii A. Amniotic membrane transplantation. Iran J Ophthalmic Res. 2007;2:1:58–75.

21. Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011;108(14):243–248. doi: 10.3238/arztebl.2011.0243.

22. Panda A. Amniotic membrane transplantation in ophthalmology (fresh v preserved tissue). British Journal of Ophthalmology. 1999;83:1409. doi: 10.1136/bjo.83.12.1409b.

23. Fedorova EA, Slonimsky AYu, Batmanov YuE. Method for preserving the amniotic membrane: Patent RU 2267922, 20.01.2006 (In Russ.).

24. Milyudin ES, Zolotarev AV, Volova LT. Method for preserving the amniotic membrane: Patent RU 2214091, 20.10.2003 (In Russ.).

25. Bikbov MM, Khalimov AR, Kazakbaev RA. Method for preserving the amniotic membrane: Patent RU 2780475, 23.09.2022 (In Russ.).

26. Iwasaki K, Komaki M, Yokoyama N. Periodontal regeneration using periodontal ligament stem cell-transferred amnion. Tissue Eng Part A. 2014;20(3–4):693–704. doi: 10.1089/ten.TEA.2013.0017.

27. Tang K, Wu J, Xiong Z. Human acellular amniotic membrane: A potential osteoinductive biomaterial for bone regeneration. J Biomater Appl. 2018;32(6):754–764. doi: 10.1177/0885328217739753.

28. Samoilov AS, Astrelina TA, Brumberg VA. Method for obtaining an acellular matrix of the amniotic membrane for subsequent reconstruction of tissue defects: Patent RU 2751353, 13.07.2021 (In Russ.).

29. Walkden A. Amniotic Membrane Transplantation in Ophthalmology: An Updated Perspective. Clin Ophthalmol. 2020;14:2057–2072. doi: 10.2147/OPTH.S208008.

30. Fenelon M, Maurel DB, Siadous R. Comparison of the impact of preservation methods on amniotic membrane properties for tissue engineering applications. Mater Sci Eng C Mater Biol Appl. 2019;104:109903. doi: 10.1016/j.msec.2019.109903.

31. Burman S, Tejwani S, Vemuganti GK, Gopinathan U, Sangwan VS. Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank. 2004;5(3):161–175. doi: 10.1023/B:CATB.0000046067.25057.0a.

32. Hofmann N, Salz A-K, Kleinhoff K. AmnioClip-Plus as Sutureless Alternative to Amniotic Membrane Transplantation to Improve Healing of Ocular Surface Disorders. Transplantology. 2021;2(4):425–432. doi: 10.3390/transplantology2040040.

33. Fan J, Wang M, Zhong F. Improvement of Amniotic Membrane Method for the Treatment of Corneal Perforation. Biomed Res Int. 2016;2016:1693815. doi: 10.1155/2016/1693815.

34. Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol. 1999;83(4):399–402. doi: 10.1136/bjo.83.4.399.

35. Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SC. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol. 2002;86(6):640–645. doi: 10.1136/bjo.86.6.640.

36. Bikbov MM, Usubov EL, Rakhimova EM, Rusakova YuA. Endothelial keratoplasty (literature review). Point of the view. East-West. 2020;1:88–91 (In Russ.). doi: 10.25276/2410-1257-2020-1-88-91.

37. Röck T, Bartz-Schmidt KU, Landenberger J, Bramkamp M, Röck D. Amniotic Membrane Transplantation in Reconstructive and Regenerative Ophthalmology. Ann Transplant. 2018 Mar 6;23:160–165. doi: 10.12659/AOT.906856.

38. Bikbov MM, Usubov EL, Zaynetdinov AF. Penetrating and anterior lamellar keratoplasty. Point of the view. East-West. 2019;1:89–92 (In Russ.). doi: 10.25276/24101257-2019-1-89-92.

39. Seitz B. Amnionmembrantransplantation. Eine unverzichtbare Therapieoption bei persistierenden kornealen Epitheldefekten [Amniotic membrane transplantation. An indispensable therapy option for persistent corneal epithelial defects]. Ophthalmologe. 2007;104(12):1075–1079. German. doi: 10.1007/s00347-007-1661-3.

40. Bikbov MM, Usubov EL, Khalimov AR. Method for biocoating of injured cornea: Patent RU 2813951, 20.02.2024 (In Russ.).

41. Sippel KC, Ma JJ, Foster CS. Amniotic membrane surgery. Curr Opin Ophthalmol. 2001;12(4):269–281. doi: 10.1097/00055735-200108000-00006.

42. Inamochi A, Tomioka A, Kitamoto K. Simple oral mucosal epithelial transplantation in a rabbit model. Sci Rep. 2019;9(1):18088. doi: 10.1038/s41598-019-54571-7.

43. Tarabrina VA, Gavrilyuk IO, Churashov SV. Effect of Platelet-Riched Plasma on Corneal Epithelium Regeneration during Its Chronic Erosion (Experimental Study). Ophthalmology in Russia. 2021;18(3):552–559 (In Russ.). doi: 10.18008/18165095-2021-3-552-559.

44. Borroni D, Wowra B, Romano V. Boyadzhieva M, Ponzin D, Ferrari S, Ahmad S, Parekh M. Simple limbal epithelial transplantation: a review on current approach and future directions. Surv Ophthalmol. 2018;63(6):869–874. doi: 10.1016/j.survophthal.2018.05.003.

45. Ozek D, Karaca EE, Evren Kemer O. Simple limbal epithelial transplantation method in the treatment of unilateral limbal stem cell deficiency due to chemical burn. Eur Eye Res 2021;1:31–36. doi: 10.14744/eer.2021.32032.

46. Sugiyama H, Maeda K, Yamato M. Human adipose tissue-derived mesenchymal stem cells as a novel feeder layer for epithelial cells. J Tissue Eng Regen Med. 2008;2(7):445–449. doi: 10.1002/term.111.

47. Nakamura T, Ang LP, Rigby H. The use of autologous serum in the development of corneal and oral epithelial equivalents in patients with Stevens-Johnson syndrome. Invest Ophthalmol Vis Sci. 2006;47(3):909–916. doi: 10.1167/iovs.05-1188.

48. Nakamura T, Inatomi T, Sotozono C, Koizumi N, Kinoshita S. Ocularsurface reconstruction using stem cell and tissue engineering. Prog Retin Eye Res. 2016;51:187– 207. doi: 10.1016/j.preteyeres.2015.07.003.

49. Nishida K, Yamato M, Hayashida Y. Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation. 2004;77(3):379–385. doi: 10.1097/01.TP.0000110320.45678.30.

50. Dubovikov AS, Gavrilyuk IO, Kulikov AN. Limbal stem cell deficiency: etiology, pathogenesis, priniciples and prospects of surgical treatment. Russian Ophthalmological Journal. 2019;12(1):103–111 (In Russ.). doi: 10.21516/2072-0076-2019-121-103-111.

51. Khalimov AR, Surkova VK, Kazakbaeva GM, Usubov EL, Khalimova LI, Zaynullina NB. Features of morphological and ultrastructural organization of the cornea (literature review). Acta biomedica scientifica. 2022;7(6):194–202 (In Russ.). doi: 10.29413/ABS.2022-7.6.19.

52. Pérez ML, Barreales S, Sabater-Cruz N. Amniotic membrane extract eye drops: a new approach to severe ocular surface pathologies. Cell Tissue Bank. 2022;23(3):473–481. doi: 10.1007/s10561-021-09962-4.

53. Sabater-Cruz N, Figueras-Roca M, Ferrán-Fuertes M. Amniotic membrane extract eye drops for ocular surface diseases: use and clinical outcome in real-world practice. Int Ophthalmol. 2021;41:2973–2979. doi: 10.1007/s10792-021-01856-4.

54. Maltsev DS, Rudko AS, Kulikov AN, Chernysh VF. The effect of amniotic membrane extract on epithelialization and neovascularization in models of corneal damage. Pacific Medical Journal. 2018;2:46–49 (In Russ.). doi: 10.17238/PmJ16091175.2018.2.46–49.

55. Chen L, Dahshan D, Mauger T. Fungal keratitis after amniotic membrane placement. Am J OphthalmolCase Rep. 2023;33:101972. doi: 10.1016/j.ajoc.2023.101972.

56. Soda R, Fukuoka H, Sotozono C. A Case of Recurrent Fungal Keratitis PostAmniotic Membrane Transplantation for Corneal Perforation. Case Rep Ophthalmol. 2022;13(1):147–153. doi: 10.1159/000522369.

57. Hori Y, Inoue R, Ikuno Y. Severe methicillin-resistant Staphylococcus aureus infection after multilayer amniotic membrane transplantation. Jpn J Ophthalmol. 2009;53(1):61–62. doi: 10.1007/s10384-008-0616-9.

58. Adds PJ, Hunt C, Hartley S. Bacterial contamination of amniotic membrane. Br J Ophthalmol. 2001;85(2):228–230. doi: 10.1136/bjo.85.2.228.

59. Gabler B, Lohmann CP. Hypopyon after repeated transplantation of human amniotic membrane onto the corneal surface. Ophthalmology. 2000;107(7):1344–1346. doi: 10.1016/s0161-6420(00)00167-6.

60. Srinivasan R, Gupta A, Kaliaperumal S. Hypopyon iritis after primary fresh amniotic membrane transplantation. Cornea. 2007;26(10):1275–1276. doi: 10.1097/ICO.0b013e31814b8b94.

61. Fernandes M, Sridhar MS, Sangwan VS, Rao GN. Amniotic membrane transplantation for ocular surface reconstruction. Cornea. 2005;24(6):643–653. doi: 10.1097/01.ico.0000151501.80952.c5.

62. Bikbov MM, Usubov EL, Pokhilko NI. Synopsis of the treatment of perforated corneal ulcers using amniotic membrane. Modern technologies in ophthalmology. 2024;4:50 (In Russ.). doi: 10.25276/2312-4911-2024-4-50.

63. Bikbov MM, Babushkin AE, Zajnutdinova GH, Matyuhina EN. Analysis of the dynamics of some inflammatory diseases of anterior segment of an eye in the Republic of Bashkortostan. RMZh. Klinicheskaya oftalmologiya. 2016;1:34–39 (In Russ.).